The association between glioma (GBM and LGG) and the beneficial effects exerted by TMZ in cancer was further observed and evaluated using cBioPortal with6 genes (CDKN2A, EGFR, HRAS, KRAS, PTEN and TP53) identified in the glioma pathway. Here, KRAS is linked to central nervous system cancer.